The short version of WADA prohibited list fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-01-06. Anything still debated is marked as such rather than presented as settled.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C | Lyophilized peptide; protect from moisture and light. |
| Typical analytical method | HPLC and mass spectrometry | Used to confirm identity and estimate purity. |
| Common synonyms | AOD9604; hGH 176-191 | Naming varies by supplier and publication. |
| Disulfide bonds | One | Affects folded structure and stability. |
| Typical research purity | ≥95% | Value depends on supplier and analytical method. |
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
Inflammation (from Latin: inflammatio) is part of the biological defence response of body tissues. Inflammatory immunovascular responses can be triggered by a broad range of stimuli, including physical trauma, "dead, damaged, malfunctioning or stressed tissues", pathogens, irritants, toxins, overuse, autoimmunity, allergens, and foreign bodies (e.g. silica and asbestos). The five cardinal signs are heat, pain, redness, swelling, and loss of function (Latin calor, dolor, rubor, tumor, and functio laesa). Inflammation is a generic response, and therefore is considered a mechanism of innate immunity, not adaptive immunity. It involves immune cells, blood vessels, and molecular mediators. The function of inflammation is to eliminate the initial cause of cell injury, clear out damaged cells and tissues, and initiate tissue repair. Too little inflammation can lead to progressive tissue destruction by the harmful stimulus (e.g. bacteria) and compromise the survival of the organism, but too much inflammation, in the form of chronic inflammation, is associated with various diseases, such as hay fever, periodontal disease, atherosclerosis, and osteoarthritis. Inflammation can be classified as acute or chronic. Acute inflammation is the initial response of the body to harmful stimuli, and is achieved by the increased movement of plasma and leukocytes (in particular granulocytes) from the blood into the injured tissues.
==== Sustainable agriculture and food production ==== Adopting more sustainable production practices is another important resilience-enhancing strategy. Moving towards more sustainable agriculture and food production involves protecting nature; restoring and rehabilitating natural environments; and sustainably managing food production systems. Agroecology is one approach that can help producers adapt to and mitigate climate change and there is increasing evidence of its benefits for the environment, biodiversity, farmers' incomes, adaptation to climate change, and resilience to multiple shocks and stresses. Climate-smart agriculture (CSA) is another resilience-enhancing approach, which aims to promote food security, resilient livelihoods and climate-resilient agriculture. It is an integrated approach to managing landscapes – cropland, livestock, forests and fisheries – that address the interlinked challenges of food security and climate change. Additionally, significant reductions in food loss and waste, better resource-use efficiency and trade have an important role, as imports may be needed to fill domestic deficits where there are natural resource constraints.
His contemporary Alfred Russel Wallace also noted these variations and the geographical separations between different forms leading to the study of biogeography. Wallace was influenced by the work of Philip Lutley Sclater on the distribution patterns of birds.
In 2024, Sinclair resigned as the President of The Academy for Health and Lifespan Research, an organization made up of a group of scientists that Sinclair had co-founded. The resignation came after what The Wall Street Journal described as a "cascade" of resignations from outraged members of The Academy after Sinclair and his brother announced that Animal Bioscience had proven that a supplement for dogs with undisclosed ingredients reversed aging. The claim was also met with criticism and skepticism from other longevity researchers.
Sources: en.wikipedia.org
== Purification == Synthesized carbon nanotubes typically contain impurities and most importantly different chiralities of carbon nanotubes. Therefore, multiple methods have been developed to purify them including polymer-assisted, density gradient ultracentrifugation (DGU), chromatography and aqueous two-phase extraction (ATPE). These methods have been reviewed in multiple articles. Certain polymers selectively disperse or wrap CNTs of a particular chirality, metallic character or diameter. For example, poly(phenylenevinylenes) disperse CNTs of specific diameters (0.75–0.84 nm) and polyfluorenes are highly selective for semiconducting CNTs. Separation involves mainly two steps: sonicate the mixture (CNTs and polymers in solvent), then centrifuge. The supernatant will contain the desired CNTs. Density gradient ultracentrifugation is based on the density difference of CNTs, so that different components are layered in centrifuge tubes under centrifugal force. Chromatography-based methods include size exclusion (SEC), ion-exchange (IEX) and gel chromatography. For SEC, CNTs are separated due to the difference in size using a stationary phase with different pore size. As for IEX, the separation is achieved based on their differential adsorption and desorption onto chemically functionalized resins packed in an IEX column, so understanding the interaction between CNTs mixtures and resins is important. The first IEX was reported to separate DNA-SWCNTs. Gel chromatography is based on the partition of CNTs between stationary and mobile phase.
== Comparison with other theories of life == The hypercycle is just one of several current theories of life, including the chemoton of Tibor Gánti, the (M,R) systems of Robert Rosen, autopoiesis (or self-building) of Humberto Maturana and Francisco Varela, and the autocatalytic sets of Stuart Kauffman, similar to an earlier proposal by Freeman Dyson. All of these (including the hypercycle) found their original inspiration in Erwin Schrödinger's book What is Life? but at first they appear to have little in common with one another, largely because the authors did not communicate with one another, and none of them made any reference in their principal publications to any of the other theories. Nonetheless, there are more similarities than may be obvious at first sight, for example between Gánti and Rosen. Until recently there have been almost no attempts to compare the different theories and discuss them together.
== Sensitivity == Depending on the analyte, an ECD can be 10-1000 times more sensitive than a flame ionization detector (FID), and one million times more sensitive than a thermal conductivity detector (TCD). An ECD has a limited dynamic range and finds its greatest application in analysis of halogenated compounds. The detection limit for electron capture detectors is 5 femtograms per second (fg/s) and the detector commonly exhibits a 10,000-fold linear range. This made it possible to detect halogenated compounds such as pesticides and CFCs, even at levels of only one part per trillion (ppt), thus revolutionizing our understanding of the atmosphere and pollutants.
=== Cattle === Entire herds of cattle are often marked with a single freeze brand to indicate where they belong or to whom they should be returned. Other means of achieving the same end include ear tags, ear notches, ear tattoos, and electronic identification by subcutaneous microchipping, ear tag microchips or rumen bolus microchips retained in a cow's stomach. These are often used in conjunction with freeze branding, where one method serves to distinguish an individual animal and the other, usually the freeze brand, denoting the herd. Although it is generally accepted that freeze branding is less painful than hot-iron branding, it is still less frequently seen in cattle than the traditional technique. This is because freeze branding requires more expensive materials, some of which are difficult to store and distribute. Hot-branding is comparatively simple and cheap, as all that is required are a fire and the branding iron.
== Business career == Newsom and a group of investors created the company PlumpJack Associates L.P. on May 14, 1991. The group started the PlumpJack Winery in 1992 with the financial help of his family friend Gordon Getty. PlumpJack was the name of an opera written by Getty, who invested in 10 of Newsom's 11 businesses. Getty told the San Francisco Chronicle that he treated Newsom like a son and invested in his first business venture because of that relationship. According to Getty, later business investments were because of "the success of the first". One of Newsom's early interactions with government occurred when Newsom resisted the San Francisco Department of Public Health's requirement to install a sink at his PlumpJack wine store. The Health Department argued that wine was a food and required the store to install a $2,700 sink in the carpeted wine shop on the grounds that the shop needed the sink for a mop. When Newsom was later appointed supervisor, he told the San Francisco Examiner: "That's the kind of bureaucratic malaise I'm going to be working through." The business grew to an enterprise with more than 700 employees. The PlumpJack Cafe Partners L.P. opened the PlumpJack Café, also on Fillmore Street, in 1993. Between 1993 and 2000, Newsom and his investors opened several other businesses that included the PlumpJack Squaw Valley Inn with a PlumpJack Café (1994), a winery in Napa Valley (1995), the Balboa Café Bar and Grill (1995), the PlumpJack Development Fund L.P.
Sources: en.wikipedia.org
No. Major drug regulators have not approved AOD-9604 for weight loss or any other therapeutic indication. It remains an investigational compound studied in research settings.
The World Anti-Doping Agency classifies it as a prohibited peptide hormone. Athletes under anti-doping rules are not permitted to use it. Its presence can trigger a doping violation.
It is a fragment of growth hormone rather than a substance that signals the pituitary to release more hormone. Studies have not shown a consistent rise in IGF-1 or full growth hormone. Its metabolic effects, if any, appear separate from those of the complete hormone.
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.